A Digital Health App to Assess Decisional Capacity to Provide Informed Consent: Protocol for a Randomized Controlled Trial

Robert D Furberg, Melissa Raspa, Anne C Wheeler, Lauren A McCormack, Donald B Bailey, Robert D Furberg, Melissa Raspa, Anne C Wheeler, Lauren A McCormack, Donald B Bailey

Abstract

Background: Any study with human subjects must have a robust consent process to ensure that participants understand the study and can decide whether they want to be involved. Investigators must determine whether a potential study participant is able to make an informed decision and what modifications or supports are needed to maximize participation in decision making. A variety of approaches have been used to modify consent forms and the consent process to increase the research participants' decisional capacity. This protocol describes a randomized controlled trial (RCT) of a digital health app to support decision making among individuals contemplating providing consent to participate in a clinical trial.

Objective: The objective of this RCT will be to determine if the use of a tablet-based app facilitates greater participation in and satisfaction with the consent process compared with standard practice and identify which individual factors are associated with better response to the decision aid. We hypothesize that the tablet-based version of the consent process will promote more informed decision making, including decisions that are more consistent with individual preferences and values expressed during qualitative data collection.

Methods: A two-arm RCT will be conducted in a sample of approximately 100 individuals with fragile X syndrome in their homes across the United States.

Results: Data analysis will be completed by late 2018.

Conclusions: By developing and testing a novel consent decision aid, we will have a better understanding of whether and how technological support can optimize the fit between the decisional capacity and the decisional process.

Trial registration: ClinicalTrials.gov NCT02465931; https://ichgcp.net/clinical-trials-registry/NCT02465931 (Archived by WebCite at http://www.webcitation.org/72Q3xJQAw).

International registered report identifier (irrid): PRR1-10.2196/10360.

Keywords: clinical trial; decision support techniques; digital health; ethics; fragile X syndrome; informed consent.

Conflict of interest statement

Conflicts of Interest: None declared.

©Robert D Furberg, Melissa Raspa, Anne C Wheeler, Lauren A McCormack, Donald B Bailey. Originally published in JMIR Research Protocols (http://www.researchprotocols.org), 19.11.2018.

Figures

Figure 1
Figure 1
FXSDA screenshot.
Figure 2
Figure 2
FXSDA screenshot.
Figure 3
Figure 3
FXSDA screenshot.

References

    1. Department of Health‚ Education‚Welfare. National Commission for the Protection of Human Subjects of BiomedicalBehavioral Research The Belmont Report. Ethical principles and guidelines for the protection of human subjects of research. J Am Coll Dent. 2014;81(3):4–13.
    1. Freedman R. Ethical challenges in the conduct of research involving persons with mental retardation. Ment Retard. 2001 Apr;39(2):130–41. doi: 10.1352/0047-6765(2001)039<0130:ECITCO>;2.
    1. Hall S, Burns David D, Lightbody Amy A, Reiss Allan L. Longitudinal changes in intellectual development in children with Fragile X syndrome. J Abnorm Child Psychol. 2008 Aug;36(6):927–39. doi: 10.1007/s10802-008-9223-y.
    1. Loesch D, Huggins Richard M, Hagerman Randi J. Phenotypic variation and FMRP levels in fragile X. Ment Retard Dev Disabil Res Rev. 2004;10(1):31–41. doi: 10.1002/mrdd.20006.
    1. Raspa M, Wheeler Anne C, Riley Catharine. Public Health Literature Review of Fragile X Syndrome. Pediatrics. 2017 Jun;139(Suppl 3):S153–S171. doi: 10.1542/peds.2016-1159C.
    1. Bailey D, Raspa Melissa, Olmsted Murrey, Holiday David B. Co-occurring conditions associated with FMR1 gene variations: findings from a national parent survey. Am J Med Genet A. 2008 Aug 15;146A(16):2060–9. doi: 10.1002/ajmg.a.32439.
    1. Baker S, Hooper S, Skinner M, Hatton D, Schaaf J, Ornstein P, Bailey D. Working memory subsystems and task complexity in young boys with Fragile X syndrome. J Intellect Disabil Res. 2011 Jan;55(1):19–29. doi: 10.1111/j.1365-2788.2010.01343.x.
    1. Hooper S, Hatton Deborah, Sideris John, Sullivan Kelly, Hammer Julie, Schaaf Jennifer, Mirrett Penny, Ornstein Peter A, Bailey Donald P. Executive functions in young males with fragile X syndrome in comparison to mental age-matched controls: baseline findings from a longitudinal study. Neuropsychology. 2008 Jan;22(1):36–47. doi: 10.1037/0894-4105.22.1.36.
    1. Ornstein P, Schaaf Jennifer M, Hooper Stephen R, Hatton Deborah D, Mirrett Penny, Bailey Donald B. Memory skills of boys with fragile X syndrome. Am J Ment Retard. 2008 Nov;113(6):453–65. doi: 10.1352/2008.113:453-465.
    1. Sullivan K, Hatton DD, Hammer J, Sideris J, Hooper S, Ornstein PA, Bailey DB. Sustained attention and response inhibition in boys with fragile X syndrome: measures of continuous performance. Am J Med Genet B Neuropsychiatr Genet. 2007 Jun 05;144B(4):517–32. doi: 10.1002/ajmg.b.30504.
    1. Roberts J, Schaaf Jennifer M, Skinner Martie, Wheeler Anne, Hooper Stephen, Hatton Deborah D, Bailey Donald B. Academic skills of boys with fragile X syndrome: profiles and predictors. Am J Ment Retard. 2005 Mar;110(2):107–20. doi: 10.1352/0895-8017(2005)110<107:ASOBWF>;2.
    1. Bailey D, Raspa Melissa, Holiday David, Bishop Ellen, Olmsted Murrey. Functional skills of individuals with fragile x syndrome: a lifespan cross-sectional analysis. Am J Intellect Dev Disabil. 2009 Jul;114(4):289–303. doi: 10.1352/1944-7558-114.4.289-303.
    1. Dölen Gül, Carpenter Randall L, Ocain Timothy D, Bear Mark F. Mechanism-based approaches to treating fragile X. Pharmacol Ther. 2010 Jul;127(1):78–93. doi: 10.1016/j.pharmthera.2010.02.008.
    1. Hagerman R, Berry-Kravis E, Kaufmann WE, Ono MY, Tartaglia N, Lachiewicz A, Kronk R, Delahunty C, Hessl D, Visootsak J, Picker J, Gane L, Tranfaglia M. Advances in the treatment of fragile X syndrome. Pediatrics. 2009 Jan;123(1):378–90. doi: 10.1542/peds.2008-0317.
    1. Bjorn E, Rossel P, Holm S. Can the written information to research subjects be improved?--an empirical study. Journal of Medical Ethics. 1999 Jun 01;25(3):263–267. doi: 10.1136/jme.25.3.263.
    1. Dresden G, Levitt M A. Modifying a standard industry clinical trial consent form improves patient information retention as part of the informed consent process. Acad Emerg Med. 2001 Mar;8(3):246–52.
    1. Murphy D, O'Keefe Z H, Kaufman A H. Improving comprehension and recall of information for an HIV vaccine trial among women at risk for HIV: reading level simplification and inclusion of pictures to illustrate key concepts. AIDS Educ Prev. 1999 Oct;11(5):389–99.
    1. Agre P, Campbell Frances A, Goldman Barbara D, Boccia Maria L, Kass Nancy, McCullough Laurence B, Merz Jon F, Miller Suzanne M, Mintz Jim, Rapkin Bruce, Sugarman Jeremy, Sorenson James, Wirshing Donna. Improving informed consent: the medium is not the message. IRB. 2003;Suppl 25(5):S11–S19.
    1. Dunn L, Lindamer Laurie A, Palmer Barton W, Golshan Shahrokh, Schneiderman Lawrence J, Jeste Dilip V. Improving understanding of research consent in middle-aged and elderly patients with psychotic disorders. Am J Geriatr Psychiatry. 2002;10(2):142–50.
    1. Fureman I, Meyers K, McLellan A T, Metzger D, Woody G. Evaluation of a video-supplement to informed consent: injection drug users and preventive HIV vaccine efficacy trials. AIDS Educ Prev. 1997 Aug;9(4):330–41.
    1. Aaronson N, Visser-Pol E, Leenhouts G H, Muller M J, van der Schot A C, van Dam F S, Keus R B, Koning C C, ten Bokkel Huinink W W, van Dongen J A, Dubbelman R. Telephone-based nursing intervention improves the effectiveness of the informed consent process in cancer clinical trials. J Clin Oncol. 1996 Mar;14(3):984–96. doi: 10.1200/JCO.1996.14.3.984.
    1. Fitzgerald D, Marotte Cécile, Verdier Rose Irene, Johnson Warren D, Pape Jean William. Comprehension during informed consent in a less-developed country. Lancet. 2002 Oct 26;360(9342):1301–2. doi: 10.1016/S0140-6736(02)11338-9.
    1. Stiles P, Poythress N G, Hall A, Falkenbach D, Williams R. Improving understanding of research consent disclosures among persons with mental illness. Psychiatr Serv. 2001 Jun;52(6):780–5. doi: 10.1176/appi.ps.52.6.780.
    1. Wirshing D, Wirshing W C, Marder S R, Liberman R P, Mintz J. Informed consent: assessment of comprehension. Am J Psychiatry. 1998 Nov;155(11):1508–11. doi: 10.1176/ajp.155.11.1508.
    1. Goldsmith L, Skirton Heather, Webb Christine. Informed consent to healthcare interventions in people with learning disabilities--an integrative review. J Adv Nurs. 2008 Dec;64(6):549–63. doi: 10.1111/j.1365-2648.2008.04829.x.
    1. Arscott K, Dagnan D, Kroese B S. Assessing the ability of people with a learning disability to give informed consent to treatment. Psychol Med. 1999 Nov;29(6):1367–75.
    1. Cea CD, Fisher Celia B. Health care decision-making by adults with mental retardation. Ment Retard. 2003 Apr;41(2):78–87. doi: 10.1352/0047-6765(2003)041<0078:HCDMBA>;2.
    1. Dye L, Hare DJ, Hendy S. Capacity of People with Intellectual Disabilities to Consent to Take Part in a Research Study. J Appl Res Int Dis. 2007 Mar;20(2):168–174. doi: 10.1111/j.1468-3148.2006.00310.x.
    1. Fisher C, Cea Christine D, Davidson Philip W, Fried Adam L. Capacity of persons with mental retardation to consent to participate in randomized clinical trials. Am J Psychiatry. 2006 Oct;163(10):1813–20. doi: 10.1176/ajp.2006.163.10.1813.
    1. Wong J, Clare C H, Holland A J, Watson P C, Gunn M. The capacity of people with a 'mental disability' to make a health care decision. Psychol Med. 2000 Mar;30(2):295–306.
    1. Morris C, Niederbuhl J M, Mahr J M. Determining the capability of individuals with mental retardation to give informed consent. Am J Ment Retard. 1993 Sep;98(2):263–72.
    1. Cleaver S, Ouellette-Kuntz H, Sakar A. Participation in intellectual disability research: a review of 20 years of studies. J Intellect Disabil Res. 2010 Mar;54(3):187–93. doi: 10.1111/j.1365-2788.2010.01256.x.
    1. Swaine J, Parish S L, Luken K, Atkins L. Recruitment and consent of women with intellectual disabilities in a randomised control trial of a health promotion intervention. J Intellect Disabil Res. 2011 May;55(5):474–83. doi: 10.1111/j.1365-2788.2011.01399.x.
    1. Mazzocco M. Math learning disability and math LD subtypes: evidence from studies of Turner syndrome, fragile X syndrome, and neurofibromatosis type 1. J Learn Disabil. 2001;34(6):520–33. doi: 10.1177/002221940103400605.
    1. Cornish K, Munir F, Cross G. Differential impact of the FMR-1 full mutation on memory and attention functioning : a neuropsychological perspective. J Cogn Neurosci. 2001 Jan 01;13(1):144–50.
    1. Palmer SB, Wehmeyer ML, Davies DK, Stock SE. Family members' reports of the technology use of family members with intellectual and developmental disabilities. J Intellect Disabil Res. 2012 Apr;56(4):402–14. doi: 10.1111/j.1365-2788.2011.01489.x.
    1. Hirsch Irl B, Martinez Joe, Dorsey E Ray, Finken Gerald, Fleming Alexander, Gropp Chris, Home Philip, Kaufer Daniel I, Papapetropoulos Spyros. Incorporating Site-less Clinical Trials Into Drug Development: A Framework for Action. Clin Ther. 2017 May;39(5):1064–1076. doi: 10.1016/j.clinthera.2017.03.018.
    1. Appelbaum PS, Grisso T. MacArthur competence assessment tool for clinical research. Sarasota, FL: Professional Resource Press; 2001.
    1. Carpenter W, Gold J M, Lahti A C, Queern C A, Conley R R, Bartko J J, Kovnick J, Appelbaum P S. Decisional capacity for informed consent in schizophrenia research. Arch Gen Psychiatry. 2000 Jun;57(6):533–8.
    1. Karlawish JHT, Casarett DJ, James BD, Xie SX, Kim SYH. The ability of persons with Alzheimer disease (AD) to make a decision about taking an AD treatment. Neurology. 2005 May 10;64(9):1514–9. doi: 10.1212/01.WNL.0000160000.01742.9D.
    1. Fisher CB, Cea CD, Davidson PW, Fried AL. Capacity of persons with mental retardation to consent to participate in randomized clinical trials. Am J Psychiatry. 2006 Oct;163(10):1813–20. doi: 10.1176/ajp.2006.163.10.1813.
    1. Furberg RD, Ortiz AM, Moultrie RR, Raspa M, Wheeler AC, McCormack LA, Bailey DB. A Digital Decision Support Tool to Enhance Decisional Capacity for Clinical Trial Consent: Design and Development. JMIR Res Protoc. 2018 Jun 06;7(6):e10525. doi: 10.2196/10525.
    1. Furberg RD, Ortiz AM, Zulkiewicz BA, Hudson JP, Taylor OM, Lewis MA. Supporting Tablet Configuration, Tracking, and Infection Control Practices in Digital Health Interventions: Study Protocol. JMIR Res Protoc. 2016 Jun 27;5(2):e136. doi: 10.2196/resprot.5400.
    1. Jimison HB, Sher P. Advances in presenting health information to patients. In: Chapman GB, Sonnenberg FA, editors. Decision making in health care: Theory, psychology, and application. Cambridge: Cambridge University Press; 2000. pp. 334–61.
    1. Bailey JD, Raspa Melissa, Holiday David, Bishop Ellen, Olmsted Murrey. Functional skills of individuals with fragile x syndrome: a lifespan cross-sectional analysis. Am J Intellect Dev Disabil. 2009 Jul;114(4):289–303. doi: 10.1352/1944-7558-114.4.289-303.

Source: PubMed

Sponsors en medewerkers

Medische omstandigheden

Geneesmiddelinterventies

3
Abonneren